28 October 2009 Business
Industry news, November 2009
Thermo Fisher Scientific has agreed to sell three of its analytical technology divisions to GE Healthcare for just over $1 billion (£645 million). The move is intended to satisfy the demands of US competition regulators and speed up final approval for Thermo’s ongoing takeover of Life Technologies.
GE will take over Thermo’s cell culture supplies, gene modulation and magnetic beads businesses, which are expected to generate combined sales in the region of $250 million for 2013.
19 April 2013 Business
Equipment suppliers unite, bringing Thermo into life sciences and sequencing markets
28 August 2015 In the Pipeline
Graduate research is likely the most risky time of a chemist’s career, says Derek Lowe